Opendata, web and dolomites

MABIOS SIGNED

The first microalgae platform for the production of anticancer biopharmaceuticals

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MABIOS project word cloud

Explore the words cloud of the MABIOS project. It provides you a very rough idea of what is the project "MABIOS" about.

microalgae    showcase    mabios    formulate    lower    plan    small    treatments    first    price    molecules    drugs    start    patients    recombinant    revolutionize    manufacturing    business    investor    oncologic    advantages    expensive    peptides    biomanufacturing    biorefineries    works    opportunity    cancer    regulatory    time    consuming    lines    drastic    create    overview    utilizing    sold    affordable    photosynthetic    market    limited    purification    manufacture    difficult    agents    utilize    world    active    cell    rate    de    risked    yield    cultivation    biopharmaceutical    meet    treatment    companies    biorefinery    biopharmaceuticals    solid    line    patient    enter    paclitaxel    demand    yields    anticancer    organisms    frontrunner    platform    urgent    living    unmet    proof    therapeutic    obstacles    starting    genetically    algae    dutch    engineered    roadmap    requiring    ease    pharmaceutical    mission    proteins    clear    scalable    tumours    ingredients    micro   

Project "MABIOS" data sheet

The following table provides information about the project.

Coordinator
MICROALGAE WORKS BV 

Organization address
address: BARGELAAN 200
city: LEIDEN
postcode: 2333 CW
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROALGAE WORKS BV NL (LEIDEN) coordinator 50˙000.00

Map

 Project objective

Manufacturing costs remain one of the major obstacles to providing effective treatment of cancer patients. Anticancer agents are often complex biopharmaceuticals that are expensive to manufacture, requiring use of living cell lines with difficult-to-control production processes, limited yields and time-consuming purification steps. There is an urgent unmet need for an improved manufacturing process of biopharmaceuticals, to meet the high demand and lower the price of oncologic treatments. We will revolutionize the way biopharmaceuticals are produced by developing a microalgae based biorefinery platform. These biorefineries will utilize genetically engineered microalgae to efficiently produce pharmaceutical agents. Microalgae are photosynthetic micro-organisms that have unique advantages as biopharmaceutical production systems, including high growth rate, ease of cultivation and low growth costs, enabling cost effective and scalable yield of active ingredients. These will be recombinant proteins, small molecules or therapeutic peptides, starting with Paclitaxel as showcase, one of the world’s best sold anticancer drugs used as the first line treatment of a several solid tumours. Our platform has the potential to become the new manufacturing method of choice for production of highly needed biopharmaceuticals. Microalgae Works is an ambitious Dutch start-up with the mission to make anticancer treatment affordable for every patient through a drastic reduction of manufacturing costs. We are supported by leading companies in the field of biomanufacturing. The MABIOS project will (1) create a clear overview of the market opportunity for micro-algae based production of paclitaxel, (2) develop a de-risked plan for the technical development of our platform, (3) evaluate the necessary regulatory roadmap to enter the market, and (4) formulate an investor-proof business plan. We aim to become the frontrunner in biopharmaceutical production utilizing microalgae.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MABIOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MABIOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More  

Path Feel (2019)

Insoles for Neuropathy and Balance Issues

Read More  

DetectInMen (2019)

Infection detection in human semen

Read More